Product image of Apretude (Cabotegravir) supplied by GNH India

Apretude

Active Ingredient:
Cabotegravir
Origin:
EU

Apretude (Cabotegravir)

Apretude is an injectable medication containing cabotegravir, used for HIV-1 pre-exposure prophylaxis (PrEP). This long-acting formulation is administered intramuscularly to help prevent HIV infection in at-risk individuals.

Manufacturer / TM Owner

Viiv Healthcare B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Apretude is primarily used for HIV-1 pre-exposure prophylaxis (PrEP) in adults and adolescents weighing at least 35 kg. It is designed for individuals at risk of HIV infection who may have difficulty adhering to daily oral medication regimens. The medication works by blocking the virus from replicating in the body, providing long-lasting protection.

Side Effects

  • Common effects of Apretude may include injection site reactions such as pain, tenderness, redness, and swelling. Some individuals may also experience headaches, fever, or fatigue. These effects are generally mild and temporary, but any persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

  • Apretude should be used with caution in individuals with a history of liver disease or hepatitis. It is important to inform your healthcare provider about all medical conditions and medications you are taking before starting Apretude. Regular monitoring and follow-up appointments are recommended to ensure the medication's effectiveness and safety.

Avoid Interactions

  • Apretude may interact with certain medications, including those that induce or inhibit liver enzymes. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol consumption should be moderated, as it may affect the body's response to the medication.

Frequently Asked Questions

Apretude is used for HIV-1 pre-exposure prophylaxis (PrEP) in adults and adolescents at risk of HIV infection.

Apretude is administered as an intramuscular injection, typically by a healthcare professional.

Common side effects include injection site reactions, headaches, fever, and fatigue.

Apretude may interact with certain medications, so it is important to discuss all current medications with your healthcare provider.

Apretude is typically administered every 2 months after an initial dosing phase.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Cabotegravir

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT